We are pleased to announce that Sebastien Stoitzner will be attending BioEquity in Bruges 12-14 May. As a key figure in our organisation’s commitment to growth and innovation within the Life Sciences sector, Sebastien’s presence at this renowned conference underlines our dedication to staying at the forefront of industry developments.
Read more “Bio-Equity 2025”
Exploring the Future of Cell and Gene Therapies at Our HealthTech Leadership Dinner in Basel
We had the pleasure of co-hosting our #HealthTech Dinner in Basel with our partners at PwC Switzerland—an evening dedicated to exploring the evolving future of cell and gene therapies.
A heartfelt thank you to our guest speakers, Joshi Venugopal (Novartis Gene Therapies & Rare Diseases) and Gunther Busam (Orchard Therapeutics – U.S.), for their thought-provoking contributions.
Sébastien Stoitzner & Thibault Vercoutere Attend the Health Innovation Agency’s CAP Tour – Marseille

Swiss Biotech Day 2025
Heiko Bruhn, a key figure at GenSearch, will be attending the Swiss Biotech Day 2025 in Basel, one of Europe’s leading biotechnology conferences.
18th Annual European Life Sciences CEO Forum

Refugee Food Paris
Last week, the GenSearch team had the opportunity to step into the kitchen at Refugee Food Paris and assist in preparing and serving meals for the community. It was a rewarding experience that brought us together in a different way—sharing time, effort, and care for those who need it most.
Read more “Refugee Food Paris”GenSearch Signs the French Charte de la Diversité
Supporting Diversity in Life Sciences Recruitment
GenSearch has signed the Charte de la Diversité, a national charter in France that encourages organisations to take practical action against discrimination and promote inclusion across all areas of employment. This commitment reflects our intention to build fairer recruitment processes and contribute to more representative leadership in the life sciences sector.

What Is the Charte de la Diversité?
Launched in 2004, the Charte de la Diversité brings together organisations that voluntarily commit to advancing diversity in the workplace. Signatories work to ensure:
- Awareness and training on diversity and inclusion
- Equal opportunities during recruitment and career progression
- Representation of societal diversity within their teams
- Transparent evaluation and accountability mechanisms
Over 5,000 companies in France have signed the Charter to date, spanning a wide range of industries and sectors.
Why This Matters for Executive Search
In executive search for the life sciences industry, inclusive hiring is essential. Signing the Charte de la Diversité strengthens GenSearch’s alignment with best practices in:
- Fair and unbiased recruitment: Ensuring all candidates are evaluated on skills, experience, and potential — not personal background
- Inclusive leadership advisory: Helping clients build diverse executive teams that reflect their markets and stakeholders
- Internal workplace equity: Promoting respect, safety, and opportunity within our own teams
Diversity in leadership leads to more robust decision-making, increased innovation, and stronger organisational performance — all critical factors in healthcare and science.
Biotech Development Day – 18/11/2024
Pauline Rambaud, GenSearch has taken part in a roundtable by France Biotech entitled : Insights on the roles of CMOs, CTOs, and CSOs in innovative health companies.
Read more “Biotech Development Day – 18/11/2024”Seasons Greetings from GenSearch
BECAUSE GREAT PROJECTS NEVER HAPPEN ALONE.
We hope you build strong alliances in 2025.
HealthTech Dinner – Basel

At the HealthTech Dinner last week, hosted by GenSearch and PwC Switzerland and, we gathered to explore one of today’s most impactful topics in healthcare: Transforming the future of obesity care.
The evening brought together brilliant minds in Pharma and Life Sciences, with insights shared by Sule Erdim Ersoy from Novo Nordisk and Hans-Juergen Woerle from Nestlé Health Science.